Blood thinner may help babies in womb with growth problems
NCT ID NCT07462182
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This trial tests whether enoxaparin, a blood thinner, can improve outcomes for babies with poor growth and low amniotic fluid. 108 pregnant women will receive either enoxaparin plus standard care or standard care alone until delivery. The study will measure live birth rates, low birth weight, and other neonatal outcomes.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- enoxaparin (a blood thinner)
- What this could lead to
- If it works, this could point toward a treatment to improve live birth rates and reduce low birth weight in complicated pregnancies.
- What could go wrong
- This is a small, early-stage trial (108 participants) that hasn't started yet. Enoxaparin carries bleeding risks, and results may not apply to all pregnancies.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for INTRAUTERINE GROWTH RESTRICTION are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Combined Military Hospital
Quetta, Balochistan, 80000, Pakistan
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Blood test may pinpoint cause of stunted fetal growth
- Scientists hunt for clues to pre-eclampsia in placenta and blood samples
- Can early speech therapy boost language in preterm babies?
- New registry aims to unlock mysteries of preterm membrane rupture
- Ultrasound program aims to halve stillbirths by spotting tiny babies earlier.
- Bolivia study to uncover hidden risks of High-Altitude pregnancy